Analyzing Sri Lanka's pharmaceutical supply chain, this report considers how measures to reduce procurement inefficiencies and build capacity would help increase supply chain resilience and boost health outcomes.
Despite pharmaceuticals being highly accessible and affordable, the report addresses vulnerabilities and explains why Sri Lanka should step up forecasting and data analytics. It shows how rationalizing the list of essential medicines can help improve economies of scale. It explains why adopting a comprehensive strategy that includes strengthening supply chain governance, improving quality assurance, and optimizing storage and distribution would help make Sri Lanka's pharmaceutical supply chain more efficient and effective.